Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-Tau accumulation in alzheimer's disease (AD) rodent models: Is fractalkine a systemic biomarker for AD?
- Merino, J.J.
- Muñetón-Gómez, V.
- Alvárez, M.-I.
- Toledano-Díaz, A.
ISSN: 1875-5828, 1567-2050
Year of publication: 2016
Volume: 13
Issue: 4
Pages: 403-412
Type: Article